Holdings
Virtus Biotech Etf
As of Jul 31, 2026, Virtus Biotech Etf reported 64 positions worth US$94.7M. Largest: Crinetics Pharmaceuticals, Inc., Kiniksa Pharmaceuticals International, Plc and Verastem, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Crinetics Pharmaceuticals, Inc. | 39,373 | US$3.29M | +20,630 | Jul 31, 2026 |
| Kiniksa Pharmaceuticals International, Plc | 26,155 | US$1.94M | +3,401 | Jul 31, 2026 |
| Verastem, Inc. | 331K | US$1.92M | new | Jul 31, 2026 |
| Precigen, Inc. | 305K | US$1.91M | new | Jul 31, 2026 |
| Omeros Corporation | 155K | US$1.84M | new | Jul 31, 2026 |
| Nuvation Bio Inc. | 276K | US$1.75M | +164K | Jul 31, 2026 |
| Regeneron Pharmaceuticals, Inc. | 2,218 | US$1.69M | +942 | Jul 31, 2026 |
| Protagonist Therapeutics, Inc. | 12,363 | US$1.69M | new | Jul 31, 2026 |
| Acadia Pharmaceuticals Inc. | 64,350 | US$1.66M | +29,495 | Jul 31, 2026 |
| Bridgebio Pharma, Inc. | 20,315 | US$1.63M | +7,723 | Jul 31, 2026 |